Clinical Trial Update: Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

This clinical trial update reports termination of a Phase 1 safety study of XL844 in patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• XL844

Snippet

Sponsor: Exelixis | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | Status: TERMINATED